Medicxi Ventures Management (Jersey) Ltd

CIK 0001715579 · Q2 2026

13F Equity AUM

$177.4M

-81.9% QoQ

Positions

-4 QoQ

AUM Rank

#8,559

Top 68%

Skill Alpha (FF)

-0.8%/yr^ns

No Clear Edge

vs S&P +0.7%/yr (unadj.)

Quarters Tracked

~6 years

Portfolio Concentration

Top 5: 100.0%Top 10: 100.0%Top 20: 100.0%

PHAT45.6%

NEWAMSTERDAM PHARMA COMPANY42.2%

AURA12.2%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

No sector data available.

Position Sizing

Positions: 3Median: 42.19%Avg: 33.33%

0–0.5%

0(0.0%)

0.5–1%

0(0.0%)

1–3%

0(0.0%)

3–5%

0(0.0%)

5%+

3(100.0%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 3vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New0Increased0Decreased0Exited0

No position changes this quarter.

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...